Skip to main content
Toggle navigation
Login
Search
Home
Icon Legend
This session is not in your schedule.
This session is in your schedule. Click again to remove it.
Favorite
Like
Tweet
Print
Mark Qian, Ph.D.
Sr Director
Takeda Pharmaceutical Company Limited
Poster(s):
(T1030-05-31) Harnessing a Cutting-Edge Time-Lapse Flow Cytometry Platform for Enhanced Immunogenicity Assessment
Tuesday, November 11, 2025
10:30 AM - 11:30 AM
CT
(T1430-05-31) ddPCR-Based Assessment of Dendritic Cell Activation for Immunogenicity Evaluation
Tuesday, November 11, 2025
2:30 PM - 3:30 PM
CT